Welcome to Add-Aspirin

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:

  1. University Hospitals Coventry & Warwickshire
  2. Worcestershire Royal Hospital
  3. Bristol Haematology & Oncology Centre
  4. Royal Marsden Hospitals
  5. Churchill Hospital, Oxford

*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*

News

We are moving!

Please note Add-Aspirin will not have telephone access on Friday 6th October but will be responding to emails as normal. Any emergency unblinding should be performed through the trial website on this day. 

On 9th October 2017 ICTM and the Add-Aspirin Team will be moving to the new address below:

Add-Aspirin Trial

MRC Clinical Trials Unit at UCL

90 High Holborn 2nd Floor

London

WC1V 6LJ

Any post already sent will be forwarded to the new address, but please send all CRFs to the address above from 9th October onwards. Contact telephone numbers and email addresses will remain the same.

Website re-vamp!

Welcome to our new look website! All features should remain the same, but please do contact us with any feedback.

Quick Links

Register a participant

To RANDOMISE a participant please call +44 (0)20 7670 4777

Unblind a participant

Breast

We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Worcestershire Royal Hospital, Royal Marsden Hospitals, Churchill Hospital Oxford

PARTICIPANTS REGISTERED: 1699
PARTICIPANTS RANDOMISED: 1311

Colon/Rectum

We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Bristol Haematology & Oncology Centre, St James 's University Hospital, Darlington Memorial Hospital

PARTICIPANTS REGISTERED: 961
PARTICIPANTS RANDOMISED: 728

Gastro

We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters:
The Christie, St James's University Hospital, Manor Hospital, Leicester Royal Infirmary

PARTICIPANTS REGISTERED: 115
PARTICIPANTS RANDOMISED: 84

Prostate

We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters: UCHW,  University Hospital of Wales, Bristol Haematology & Oncology Centre

PARTICIPANTS REGISTERED: 764
PARTICIPANTS RANDOMISED: 594

the trial is being jointly funded by